268 related articles for article (PubMed ID: 24023728)
21. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Metz TO; Alderson NL; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
[TBL] [Abstract][Full Text] [Related]
22. Glycation of Immunoglobulin-G from Pentose Sugar: A Cause for Structural Perturbations.
Alenazi F; Saleem M; Syed Khaja AS; Zafar M; Alharbi MS; Hagbani TA; Khan MY; Ahmad S
Curr Protein Pept Sci; 2022; 23(11):773-781. PubMed ID: 36177615
[TBL] [Abstract][Full Text] [Related]
23. Glucitol-core containing gallotannins inhibit the formation of advanced glycation end-products mediated by their antioxidant potential.
Ma H; Liu W; Frost L; Kirschenbaum LJ; Dain JA; Seeram NP
Food Funct; 2016 May; 7(5):2213-22. PubMed ID: 27101975
[TBL] [Abstract][Full Text] [Related]
24. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
[TBL] [Abstract][Full Text] [Related]
25. Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes.
Adeshara K; Tupe R
Mol Biol Rep; 2016 Mar; 43(3):195-205. PubMed ID: 26874852
[TBL] [Abstract][Full Text] [Related]
26. Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Nobécourt E; Zeng J; Davies MJ; Brown BE; Yadav S; Barter PJ; Rye KA
Diabetologia; 2008 Jun; 51(6):1008-17. PubMed ID: 18437350
[TBL] [Abstract][Full Text] [Related]
27. Antiglycating potential of acesulfame potassium: an artificial sweetener.
Ali A; More TA; Hoonjan AK; Sivakami S
Appl Physiol Nutr Metab; 2017 Oct; 42(10):1054-1063. PubMed ID: 28618238
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of inhibitory effects of bioactive anthraquinones towards formation of DNA advanced glycation end products (DNA-AGEs).
Quraishi S; Nudrat S; Kumari K; Marboh EWM; Aguan K; Singha Roy A
Int J Biol Macromol; 2024 Jun; 269(Pt 2):131810. PubMed ID: 38677669
[TBL] [Abstract][Full Text] [Related]
29. Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.
Ahmad S; Farhan M
Adv Neurobiol; 2016; 12():125-51. PubMed ID: 27651252
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of advanced glycation end products by isoferulic acid and its free radical scavenging capacity: An in vitro and molecular docking study.
Arfin S; Siddiqui GA; Naeem A; Moin S
Int J Biol Macromol; 2018 Oct; 118(Pt B):1479-1487. PubMed ID: 29969636
[TBL] [Abstract][Full Text] [Related]
31. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
Khalifah RG; Baynes JW; Hudson BG
Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
[TBL] [Abstract][Full Text] [Related]
32. Ageing promotes the increase of early glycation Amadori product as assessed by epsilon-N-(2-furoylmethyl)-L-lysine (furosine) levels in rodent skin collagen. The relationship to dietary restriction and glycoxidation.
Sell DR
Mech Ageing Dev; 1997 Apr; 95(1-2):81-99. PubMed ID: 9152963
[TBL] [Abstract][Full Text] [Related]
33. Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine.
Pietkiewicz J; Bronowicka-Szydełko A; Dzierzba K; Danielewicz R; Gamian A
Protein J; 2011 Mar; 30(3):149-58. PubMed ID: 21347838
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the protective ability of thymoquinone mixture with p-cymene against bovine serum albumin (BSA) glycation: MCR-ALS analysis based on combined spectroscopic and electrochemical methods.
Benvidi A; Rezaeinasab M; Gharaghani S; Abbasi S
Int J Biol Macromol; 2018 Feb; 107(Pt B):2465-2474. PubMed ID: 29074084
[TBL] [Abstract][Full Text] [Related]
35. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a novel radical trapping and carbonyl group trapping anti-AGE agent: a pyridoxamine analogue for inhibiting advanced glycation (AGE) and lipoxidation (ALE) end products.
Culbertson SM; Enright GD; Ingold KU
Org Lett; 2003 Jul; 5(15):2659-62. PubMed ID: 12868883
[TBL] [Abstract][Full Text] [Related]
37. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
Salahuddin P; Rabbani G; Khan RH
Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
[TBL] [Abstract][Full Text] [Related]
38. Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats.
Glaeser JD; Ju D; Tawackoli W; Yang JH; Salehi K; Stefanovic T; Kanim LEA; Avalos P; Kaneda G; Stephan S; Metzger MF; Bae HW; Sheyn D
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352698
[TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction.
Chiazza F; Cento AS; Collotta D; Nigro D; Rosa G; Baratta F; Bitonto V; Cutrin JC; Aragno M; Mastrocola R; Collino M
Biomed Res Int; 2017; 2017():2682861. PubMed ID: 29214163
[TBL] [Abstract][Full Text] [Related]
40. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat.
Muellenbach EA; Diehl CJ; Teachey MK; Lindborg KA; Archuleta TL; Harrell NB; Andersen G; Somoza V; Hasselwander O; Matuschek M; Henriksen EJ
Metabolism; 2008 Oct; 57(10):1465-72. PubMed ID: 18803954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
